News Sentiment

IBRX sentiment intelligence

Immunitybio Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.22 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

85/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend active

-12.9% over one week, +15.8% over four weeks, trend active, and materially above fair value.

Latest direct headline Negative

ImmunityBio, Inc. (IBRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 85/100 classification
One-week reaction -12.9% Price reacting lower
Trend fit Trend active 15.8% over four weeks
Fair value 93.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 35
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
TradingView 9
Market source 7
Investing.com 5
Stock Titan 5
Stocktwits 4
simplywall.st 4
Simply Wall Street 3
MT Newswires 3

Event Lens

What the news is about

Classified themes
Market update 38
Earnings 13
Analyst action 2
Deals and strategy 2
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
TechStock² Direct company coverage

ImmunityBio (NASDAQ:IBRX) trades after post-Russell spike with 46% more volume

ImmunityBio (NASDAQ:IBRX) saw its stock jump 11.8% on Friday, trading with significantly higher volume (41.2 million shares), which was 46% of its past five sessions' trading volume, potentially driven by the Russell reconstitution. Despite a director's planned sale of 25,000 sha

Tone
Positive 63/100
Event
Market update
Published
27 Jun 2026 10:08
Source
TechStock²
TradingView Direct company coverage

Enterprise value to EBIT forward of ImmunityBio, Inc. – NASDAQ:IBRX

This article focuses on the "Enterprise value to EBIT forward" metric for ImmunityBio, Inc. (NASDAQ: IBRX). It appears to be an entry from a financial data platform, providing a snapshot of this specific financial ratio for the company. The content itself seems to be a page from

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 08:39
Source
TradingView
Investing.com Nigeria Direct company coverage

Form 4 Immunitybio Inc For: 26 June By Investing.com

This article from Investing.com reports on a Form 4 filing for Immunitybio Inc. dated June 26. It indicates the latest filing for the company. The article also provides IBRX's stock performance.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 04:10
Source
Investing.com Nigeria
Stock Titan Direct company coverage

ImmunityBio (NASDAQ: IBRX) director sells 25,000 shares under 10b5-1 plan

ImmunityBio (NASDAQ: IBRX) director Barry J. Simon sold 25,000 shares of common stock on June 24, 2026, at a weighted average price of $7.8763 per share. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on December 18, 2025. Following the sale,

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 01:39
Source
Stock Titan
TradingView Direct company coverage

Price to sales forward of ImmunityBio Inc – SWB:26CA

This article provides financial information for ImmunityBio Inc, traded on the Stuttgart Stock Exchange under the symbol SWB:26CA. It specifically focuses on the company's forward price to sales ratio. The content is presented by TradingView, sourcing market data from ICE Data Se

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 00:39
Source
TradingView
Los Angeles Business Journal Direct company coverage

ImmunityBio’s Stock Sees a Huge Boost

Tone
Neutral 50/100
Event
Market update
Published
09 Mar 2026 07:00
Source
Los Angeles Business Journal